SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL
Sellas Life Sciences (SLS) stock rose overnight, emerging as the top bullish pick among retail traders over IBRX, ONDS, and PYPL. Traders are eyeing the 80th event, data lock, and topline results, with some speculating on potential M&A.
Shares of Sellas Life Sciences (ticker: SLS) surged in overnight trading, becoming the most favored bullish pick among retail traders compared to ImmunityBio (IBRX), Ondas Holdings (ONDS), and PayPal (PYPL). The move comes amid anticipation of a key upcoming event for the company.
Details
According to Stocktwits, traders are watching for the 80th event, data lock, and topline results. Some are also speculating about potential merger and acquisition (M&A) activity.
Context
Sellas is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer. Any positive clinical milestone could significantly move the stock. In contrast, IBRX, ONDS, and PYPL have not seen the same level of retail enthusiasm.
What This Means for Investors
This overnight rally reflects short-term positive sentiment, but it is based on unconfirmed expectations. Investors should monitor official company announcements before making decisions.
Frequently Asked Questions
Found this useful? Share it